Drug
IDegLira clinical trials
- studies test it
- 6
- open now
- 1
- in phase 3
- 3
- first study started
- 2018
Keep track of what changes. Save the IDegLira studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Studies by the year they started
6 studies that test it; most in 2019 (3)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 3 |
| 2022 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 3
- 3
- Phase 4
- 2
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 6
Population Health Research Institute (1) · Emory University (1) · Stefano Rizza (1) · University of Campania Luigi Vanvitelli (1) · Peking University People's Hospital (1) · Xiangya Hospital of Central South University (1)
Often tested with
Tested in the same studies.
Insulin Glargine (2) · Lixisenatide (1) · Metformin (1) · Empagliflozin (1)
Studies
Open first, then newest update. How each study uses IDegLira is read from its arms, and is right about nine times in ten.
Testing it · 6
- The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 DiabetesNot yet recruitingPhase 4Peking University People's HospitalNCT06408532Written as IDegLira
- Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLiraCompletedPhase 3Population Health Research InstituteNCT03862716Written as IDegLira
- IDegLira HIGH TrialCompletedPhase 3Emory UniversityNCT03737240Written as IDegLira
- Efficacy and Safety Of Different Regimens In Patients With Type 2 Diabetes Receiving Intensive Insulin TherapyStatus unknownPhase 3Xiangya Hospital of Central South UniversityNCT05545800Written as IDegLira
- Quality of Life and Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira)CompletedNot applicableStefano RizzaNCT04190160Written as IDegLira
- Durability of Combination of Insulin and GLP-1 Receptor Agonist or SGLT-2 Inhibitors Versus Basal Bolus Insulin Regimen in Type 2 Diabetes (BEYOND)CompletedPhase 4University of Campania Luigi VanvitelliNCT04196231Written as IDegLira